A novel lipid-based solid dispersion for enhancing oral bioavailability of Lycopene - In vivo evaluation using a pig model

International Journal of Pharmaceutics

Volumn 453, Issue 2, 2013, Pages 307-314

  Faisal, Waleed ^a   Ruane O'Hora, Therese ^a   O'Driscoll, Caitriona M ^a   Griffin, Brendan T ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Gelucire 44 14; Lipid based formulation; Lycopene bioavailability; Pig model; SEDDS; Solid dispersions

Indexed keywords

LYCOPENE;

AREA UNDER THE CURVE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; IN VIVO STUDY; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SELF EMULSIFYING DRUG DELIVERY SYSTEM; SOLID STATE; X RAY DIFFRACTION;

EID: 84884156938     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.06.027     Document Type: Article

References (47)

1. Aungst, B.J., Nguyen, N.H., Rogers, N.J., Rowe, S.M., Hussain, M.A., White, S.J., Shum, L., 1997. Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses. Int. J. Pharmaceut. 156, 79-88. (Pubitemid 27400082)
2. Barker, S.A., Yap, S.P., Yuen, K.H., McCoy, C.P., Murphy, J.R., Craig, D.Q.M., 2003. An investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14. J. Control Release 91, 477-488. (Pubitemid 36976774)
3. Boileau, T.W.M., Liao, Z.M., Kim, S., Lemeshow, S., Erdman, J.W., Clinton, S.K., 2003. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J. Natl. Cancer Inst. 95, 1578-1586. (Pubitemid 37455925)
4. Caliph, S.M., Charman, W.N., Porter, C.J., 2000. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci. 89, 1073-1084.
5. Chambin, O., Jannin, V., 2005. Interest of multifunctional lipid excipients: case of Gelucire 44/14. Drug Dev. Ind. Pharm. 31, 527-534. (Pubitemid 41285730)
6. Chiou, W.L., Riegelman, S., 1971. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60, 1281-1302.
7. Corrigan, O.I., 1985. Mechanisms of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm. 11, 697-724. (Pubitemid 15067853)
8. Craig, D.Q.M., 2002. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharmaceut. 231, 131-144. (Pubitemid 34033673)
9. Davis, S.S., Illum, L., Hinchcliffe, M., 2001. Gastrointestinal transit of dosage forms in the pig. J. Pharm. Pharmacol. 53, 33-39. (Pubitemid 32123697)
10. Do, T.T., Van Speybroeck, M., Mols, R., Annaert, P., Martens, J., Van Humbeeck, J., Vermant, J., Augustijns, P., Van den Mooter, G., 2011. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate. Int. J. Pharmaceut. 414, 118-124.
11. Etminan, M., Takkouche, B., Caamano-Isorna, F., 2004. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidem. Biomar. 13, 340-345. (Pubitemid 38737456)
12. Faisal, W., O'Driscoll, C.M., Griffin, B.T., 2010. Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport. J. Pharm. Pharmacol. 62, 323-331.
13. Fei, Y., Kostewicz, E.S., Sheu, M.T., Dressman, J.B., 2013. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach. Eur. J. Pharm. Biopharm..
14. Fini, A., Moyano, J.R., Gines, J.M., Perez-Martinez, J.I., Rabasco, A.M., 2005. Diclofenac salts II. Solid dispersions in PEG6000 and Gelucire 50/13. Eur. J. Pharm. Biopharm. 60, 99-111. (Pubitemid 40545866)
15. Gartner, C., Stahl, W., Sies, H., 1997. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am. J. Clin. Nutr. 66, 116-122. (Pubitemid 27278908)
16. Gershanik, T., Benita, S., 2000. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 50, 179-188. (Pubitemid 30326696)
17. Giovannucci, E., 2005. Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. J. Nutr. 135, 2030S-2031S. (Pubitemid 41099768)
18. Giovannucci, E., Ascherio, A., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Willett, W.C., 1995. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 87, 1767-1776.
19. Griffin, B., O'Driscoll, C., 2008. Models of the Small Intestine. In: Ehrhardt, C., Kim, K.-J. (Eds.), Drug Absorption Studies. Springer US., pp. 34-76.
20. Griffin, B.T., O'Driscoll, C.M., 2006. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J. Pharm. Pharmacol. 58, 917-925. (Pubitemid 43967108)
21. Gustin, D.M., Rodvold, K.A., Sosman, J.A., Diwadkar-Navsariwala, V., Stacewicz-Sapuntzakis, M., Viana, M., Crowell, J.A., Murray, J., Tiller, P., Bowen, P.E., 2004. Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oil mixture) in healthy adult male subjects. Cancer Epidem. Biomar. Prev. 13, 850-860. (Pubitemid 38737876)
22. Hadley, C.W., Clinton, S.K., Schwartz, S.J., 2003. The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J. Nutr. 133, 727-732. (Pubitemid 36268346)
23. Hayes, R.B., Ziegler, R.G., Gridley, G., Swanson, C., Greenberg, R.S., Swanson, G.M., Schoenberg, J.B., Silverman, D.T., Brown, L.M., Pottern, L.M., Liff, J., Schwartz, A.G., Fraumeni, J.F., Hoover, R.N., 1999. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidem. Biomar. 8, 25-34. (Pubitemid 29090866)
24. Hoppe, P.P., Kramer, K., van den Berg, H., Steenge, G., van Vliet, T., 2003. Synthetic and tomato-based lycopene have identical bioavailability in humans. Eur. J. Nutr. 42, 272-278. (Pubitemid 37243586)
25. Jannin, V., Musakhanian, J., Marchaud, D., 2008. Approaches for the development of solid and semi-solid lipid-based formulations. Adv. Drug Deliv. Rev. 60, 734-746. (Pubitemid 351215578)
26. Kararli, T.T., 1995. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory-animals. Biopharm. Drug Dispos. 16, 351-380.
27. Khoo, S.M., Shackleford, D.M., Porter, C.J.H., Edwards, G.A., Charman, W.N., 2003. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharmaceut. Res. 20, 1460-1465. (Pubitemid 37164055)
28. Kim, H.S., Bowen, P., Chen, L.W., Duncan, C., Ghosh, L., Sharifi, R., Christov, K., 2003. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr. Cancer 47, 40-47. (Pubitemid 38250434)
29. Kolonel, L.N., Hankin, J.H., Whittemore, A.S., Wu, A.H., Gallagher, R.P., Wilkens, L.R., John, E.M., Howe, G.R., Dreon, D.M., West, D.W., Paffenbarger, R.S., 2000. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidem. Biomar. 9, 795-804. (Pubitemid 30660052)
30. Korytko, P.J., Rodvold, K.A., Crowell, J.A., Stacewicz-Sapuntzakis, M., Diwadkar-Navsariwala, V., Bowen, P.E., Schalch, W., Levine, B.S., 2003. Pharmacokinetics and tissue distribution of orally administered lycopene in male dogs. J. Nutr. 133, 2788-2792. (Pubitemid 37099761)
31. Larsen, A.T., Ohlsson, A.G., Polentarutti, B., Barker, R.A., Phillips, A.R., Abu-Rmaileh, R., Dickinson, P.A., Abrahamsson, B., Ostergaard, J., Mullertz, A., 2013. Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation. Eur. J. Pharm. Sci. 48, 339-350.
32. Leuner, C., Dressman, J., 2000. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50, 47-60. (Pubitemid 30326688)
33. Michaud, D.S., Giovannucci, E.L., Ascherio, A., Rimm, E.B., Forman, M.R., Sampson, L., Willett, W.C., 1998. Associations of plasma carotenoid concentrations and dietary intake of specific carotenoids in samples of two prospective cohort studies using a new carotenoid database. Cancer Epidem. Biomar. Prev. 7, 283-290. (Pubitemid 28354138)
34. Nahum, A., Hirsch, K., Danilenko, M., Watts, C.K.W., Prall, O.W.J., Levy, J., Sharoni, Y., 2001. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 20, 3428-3436. (Pubitemid 32588991)
35. O'Driscoll, C.M., 2002. Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 15, 405-415. (Pubitemid 34567104)
36. O'Driscoll, C.M., Griffin, B.T., 2008. Biopharmaceutical challenges associated with drugs with low aqueous solubility-the potential impact of lipid-based formulations. Adv. Drug Deliv. Rev. 60, 617-624.
37. Pouton, C.W., Porter, C.J.H., 2008. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 60, 625-637.
38. Re, R., Fraser, P.D., Long, M., Bramley, P.M., Rice-Evans, C., 2001. Isomerization of lycopene in the gastric milieu. Biochem. Biophys. Res. Commun. 281, 576-581. (Pubitemid 32928193)
39. Sethia, S., Squillante, E., 2004. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 272, 1-10. (Pubitemid 38293005)
40. Shi, J., Le Maguer, M., 2000. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit. Rev. Biotechnol. 20, 293-334. (Pubitemid 32056133)
41. Shu, B., Yu, W.L., Zhao, Y.P., Liu, X.Y., 2006. Study on microencapsulation of lycopene by spray-drying. J. Food Eng. 76, 664-669.
42. Stillhart, C., Cavegn, M., Kuentz, M., 2013. Study of drug supersaturation for rational early formulation screening of surfactant/co- solvent drug delivery systems. J. Pharm. Pharmacol. 65, 181-192.
43. Thomas, N., Holm, R., Garmer, M., Karlsson, J.J., Mullertz, A., Rades, T., 2013. Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs. Aaps J. 15, 219-227.
44. Vasconcelos, T., Sarmento, B., Costa, P., 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 12, 1068-1075. (Pubitemid 350186132)
45. Vertzoni, M., Fotaki, N., Kostewicz, E., Stippler, E., Leuner, C., Nicolaides, E., Dressman, J., Reppas, C., 2004. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. J. Pharm. Pharmacol. 56, 453-462. (Pubitemid 38455610)
46. Vertzoni, M., Valsami, G., Reppas, C., 2006. Plasma profiles of lycopene after single oral and intravenous administrations in dogs. J. Pharm. Pharmacol. 58, 1211-1217. (Pubitemid 44329102)
47. Wei, M.Y., Giovannucci, E.L., 2012. Lycopene, tomato products, and prostate cancer incidence: a review and reassessment in the PSA screening era. J. Oncol., 271063.